NCT04016896

Brief Summary

Using an indicated prevention approach, investigators propose to enroll 150 spousally-bereaved adults aged 60 years and older in the first 12 months after spousal death who are at high risk for major depression disorder because of subthreshold symptoms of depression. A confirmatory efficacy trial will be conducted in which participants will be randomly assigned to (a) self-monitor sleep, meals, and physical activity for 12 weeks using digital monitoring plus motivational health coaching (WELL; n=75); or (b) enhanced usual care (EUC, usual care plus study assessments, n=75). Objective actigraphic measures of the 24-hour pattern of day and nighttime activity - known as the rest-activity rhythm - will be measured to evaluate circadian rhythms as a mediator of treatment outcomes. Participants will be assessed at baseline, months 1 \& 2, post-intervention, and 3, 6,12, 18-months post-intervention. In addition, the investigators will include a subset of participants bereaved by COVID-19 (or suspected as bereaved by COVID-19). Participants in this subset will undergo the same research procedures as the main cohort. Participants in both the main cohort and subset determined to be fully eligible will be randomized into two groups with a total of: enhanced usual care (EUC; n=75) and WELL (WELL; n=75).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
151

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
1.3 years until next milestone

Study Start

First participant enrolled

October 20, 2020

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2025

Completed
1 year until next milestone

Results Posted

Study results publicly available

January 28, 2026

Completed
Last Updated

January 28, 2026

Status Verified

April 1, 2025

Enrollment Period

4.2 years

First QC Date

July 8, 2019

Results QC Date

January 9, 2026

Last Update Submit

January 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Depression Symptom Burden at 3 Months

    Depression symptoms measured by the clinician administered Hamilton Rating Scale for Depression

    baseline vs. 3 months

Secondary Outcomes (3)

  • Change From Baseline in Anxiety Symptom Burden at 3 Months

    baseline vs. 3 months

  • Change From Baseline in Complicated Grief Symptom Burden at 3 Months

    baseline vs. 3 months

  • Change From Baseline in Posttraumatic Stress Symptom Burden at 3 Months

    baseline vs. 3 months

Study Arms (2)

Widowed Elders' Lifestyle after Loss (WELL)

EXPERIMENTAL

Digital monitoring of sleep, meals, physical activity (daily); motivational health coaching (weekly); and web-based performance feedback (in real-time) for 12 weeks.

Behavioral: WIdowed Elders' LIfestyle after Loss (WELL)

Enhanced Usual Care

ACTIVE COMPARATOR

Health education, referral to mental health support, and telephone-delivered support (weekly) for 12 weeks.

Other: Enhanced Usual Care

Interventions

Digital monitoring of sleep, meals, physical activity (daily); motivational health coaching (weekly); and web-based performance feedback (in real-time) for 12 weeks.

Widowed Elders' Lifestyle after Loss (WELL)

Health education, referral to mental health support, and telephone-delivered support (weekly) for 12 weeks.

Enhanced Usual Care

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 60 years and older;
  • spousally (or partner) bereaved up to 12 months (includes bereaved as a result of COVID-19);
  • at-risk for major depressive disorder (MDD), based on high-risk markers defined as subthreshold symptoms of depression (Hamilton Depression Rating Scale score of \> or = 9), together with absence of current MDD, post-traumatic stress disorder, or persistent complex bereavement disorder

You may not qualify if:

  • current Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-5) criteria for syndromal mood, psychosis within the last 12 months;
  • dementia/cognitive impairment; Telephone Interview Cognitive Screening (TICS) \<19;
  • acute suicide risk; based on Herbeck et al. protocol for suicide risk management;
  • patients taking new psychotropic medications after spousal death to stabilize depression including antidepressants and benzodiazepines \>4 days/week for more than two months. Individuals who have been on a stable dose for at least 1 month and agree not to change during participation, unless it is medically necessary, will be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC: WPIC- Bellefield Towers

Pittsburgh, Pennsylvania, 15213, United States

Location

Related Publications (1)

  • Kazan J, Lyew T, Croswell E, Buysse DJ, Gebara MA, Karp JF, Krafty RT, Rashied AA, Reynolds CF 3rd, Rollman BL, Smagula SF, Stahl ST. A digital health intervention to stabilize the 24-hour rhythm of sleep, meals, and physical activity for reducing depression among older bereaved spouses: Protocol for a randomized controlled trial. Contemp Clin Trials. 2023 Jan;124:107016. doi: 10.1016/j.cct.2022.107016. Epub 2022 Nov 19.

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Results Point of Contact

Title
Sarah T. Stahl, PhD
Organization
University of Pittsburgh

Study Officials

  • sarah t stahl, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Psychiatry

Study Record Dates

First Submitted

July 8, 2019

First Posted

July 12, 2019

Study Start

October 20, 2020

Primary Completion

January 17, 2025

Study Completion

January 17, 2025

Last Updated

January 28, 2026

Results First Posted

January 28, 2026

Record last verified: 2025-04

Locations